Science Explorer Back to mapMap

Most cited papers from Mitsubishi Tanabe Pharma Corporation

What are the most cited papers from Mitsubishi Tanabe Pharma Corporation?

The most cited paper from Mitsubishi Tanabe Pharma Corporation is "Mechanisms of hepatic stellate cell activation" (Takuma Tsuchida, Scott L. Friedman, 2017), with 2,956 citations. Next come "A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer" (588) and "The influence of cytokines on the complex pathology of ulcerative colitis" (454).

Showing 50 of 61 papers. Every paper with more than 82 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Mechanisms of hepatic stellate cell activation Takuma Tsuchida, Scott L. Friedman · Nature Reviews Gastroenterology & Hepatology Review 10 May 2017 2,956
2 A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer Takuma Tsuchida, Youngmin A. Lee, Naoto Fujiwara et al. · Journal of Hepatology Open access 20 Mar 2018 588
3 The influence of cytokines on the complex pathology of ulcerative colitis Hiroshi Nakase, Noriko Sato, Naomi Mizuno et al. · Autoimmunity Reviews Open access 10 Dec 2021 454
4 Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis Nobuhiro Nakamoto et al. · Nature Microbiology 3 Jan 2019 429
5 CD5L/AIM Regulates Lipid Biosynthesis and Restrains Th17 Cell Pathogenicity Chao Wang et al. · Cell Open access 19 Nov 2015 409
6 Selective and direct inhibition of TRPC3 channels underlies biological activities of a pyrazole compound Shigeki Kiyonaka et al. · Proceedings of the National Academy of Sciences Open access 16 Mar 2009 390
7 Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients Koji Abe, Yasuto Itoyama, Gen Sobue et al. · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Open access 6 Oct 2014 363
8 Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease Dong I. Lee, Guangshuo Zhu, Takashi Sasaki et al. · Nature Open access Mar 2015 352
9 A comparative study of the binding modes of recently launched dipeptidyl peptidase IV inhibitors in the active site Mika Nabeno, Fumihiko Akahoshi, Hiroyuki Kishida et al. · Biochemical and Biophysical Research Communications 15 Mar 2013 311
10 Randomized Placebo-Controlled EPPIC Trials of AST-120 in CKD Gerald Schulman, Tomás Berl, Gerald J. Beck et al. · Journal of the American Society of Nephrology Open access 28 Oct 2014 281
11 Alpha-CaMKII deficiency causes immature dentate gyrus, a novel candidate endophenotype of psychiatric disorders Nobuyuki Yamasaki et al. · Molecular Brain Open access 10 Sep 2008 276
12 Effect of Canagliflozin on Renal Threshold for Glucose, Glycemia, and Body Weight in Normal and Diabetic Animal Models Yin Tong Liang, Kenji Arakawa, Kiichiro Ueta et al. · PLoS ONE Open access 15 Feb 2012 244
13 The Current Status of Drug Discovery and Development as Originated in United States Academia: The Influence of Industrial and Academic Collaboration on Drug Discovery and Development Tohru Takebe, Ryoka Imai, Shunsuke Ono · Clinical and Translational Science Open access 25 Jun 2018 241
14 How is edaravone effective against acute ischemic stroke and amyotrophic lateral sclerosis? Kazutoshi Watanabe, Masahiko Tanaka, Satoshi Yuki et al. · Journal of Clinical Biochemistry and Nutrition Open access 10 Nov 2017 231
15 Diversity and plasticity of microglial cells in psychiatric and neurological disorders Yutaka Nakagawa, Kenji Chiba · Pharmacology & Therapeutics Jul 2015 220
16 CD8+ tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells Yuzo Koda, Toshiaki Teratani, Po–Sung Chu et al. · Nature Communications Open access 22 Jul 2021 219
17 Role of Microglial M1/M2 Polarization in Relapse and Remission of Psychiatric Disorders and Diseases Yutaka Nakagawa, Kenji Chiba · Pharmaceuticals Open access 25 Nov 2014 219
18 Untargeted Metabolomic Profiling as an Evaluative Tool of Fenofibrate-Induced Toxicology in Fischer 344 Male Rats Tetsuya Ohta, Naoya Masutomi, Naohisa Tsutsui et al. · Toxicologic Pathology Open access 20 May 2009 214
19 Predicting Fraction Unbound in Human Plasma from Chemical Structure: Improved Accuracy in the Low Value Ranges Reiko Watanabe, Tsuyoshi Esaki, Hitoshi Kawashima et al. · Molecular Pharmaceutics Open access 27 Sep 2018 212
20 Cryo-EM structures capture the transport cycle of the P4-ATPase flippase Masahiro Hiraizumi, Keitaro Yamashita, Tomohiro Nishizawa et al. · Science 15 Aug 2019 205
21 Lysophospholipid Acyltransferases Mediate Phosphatidylcholine Diversification to Achieve the Physical Properties Required In Vivo T. HARAYAMA, Miki Eto, Hideo Shindou et al. · Cell Metabolism Open access 26 Jun 2014 195
22 Molecular Substrates of Altered Axonal Growth and Brain Connectivity in a Mouse Model of Schizophrenia Jun Mukai, Makoto Tamura, Karine Fénelon et al. · Neuron Open access 25 Apr 2015 190
23 Canagliflozin, an SGLT2 inhibitor, attenuates the development of hepatocellular carcinoma in a mouse model of human NASH Kumiko Shiba, Kyoichiro Tsuchiya, Chikara Komiya et al. · Scientific Reports Open access 30 Jan 2018 176
24 Isolation and Characterization of Patient-derived, Toxic, High Mass Amyloid β-Protein (Aβ) Assembly from Alzheimer Disease Brains Akihiko Noguchi et al. · Journal of Biological Chemistry Open access 17 Sep 2009 174
25 Comparison of Drug Metabolism and Its Related Hepatotoxic Effects in HepaRG, Cryopreserved Human Hepatocytes, and HepG2 Cell Cultures Yuichi Yokoyama, Yoshifumi Sasaki, Natsuko Terasaki et al. · Biological and Pharmaceutical Bulletin Open access 13 Feb 2018 162
26 Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems Eisaku Kondo, Ken Saito, Yuichi Tashiro et al. · Nature Communications Open access 17 Jul 2012 157
27 Baseline tumour necrosis factor alpha levels predict the necessity for dose escalation of infliximab therapy in patients with rheumatoid arthritis Tsutomu Takeuchi, Nobuyuki Miyasaka, Yoshihiko Tatsuki et al. · Annals of the Rheumatic Diseases Open access 9 Apr 2011 152
28 Discovery and preclinical profile of teneligliptin (3-[(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl]thiazolidine): A highly potent, selective, long-lasting and orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes Tomohiro Yoshida et al. · Bioorganic & Medicinal Chemistry Open access 16 Aug 2012 152
29 On the relationship between the two branches of the kynurenine pathway in the rat brainin vivo Laura Amori, Paolo Guidetti, Roberto Pellicciari et al. · Journal of Neurochemistry Open access 16 Feb 2009 151
30 Inhaled Fine Particles Induce Alveolar Macrophage Death and Interleukin-1α Release to Promote Inducible Bronchus-Associated Lymphoid Tissue Formation Etsushi Kuroda et al. · Immunity Open access Dec 2016 145
31 Factors Affecting Canagliflozin-Induced Transient Urine Volume Increase in Patients with Type 2 Diabetes Mellitus Hiroyuki Tanaka, Kazuhiko Takano, Hiroaki Iijima et al. · Advances in Therapy Open access 15 Dec 2016 142
32 Efficacy and safety of canagliflozin in Japanese patients with type 2 diabetes: a randomized, double‐blind, placebo‐controlled, 12‐week study Nobuya Inagaki, Kazuoki Kondo, Toru Yoshinari et al. · Diabetes Obesity and Metabolism Open access 19 Jun 2013 137
33 Efficacy and safety of canagliflozin monotherapy in Japanese patients with type 2 diabetes inadequately controlled with diet and exercise: a 24-week, randomized, double-blind, placebo-controlled, Phase III study Nobuya Inagaki, Kazuoki Kondo, Toru Yoshinari et al. · Expert Opinion on Pharmacotherapy 10 Jul 2014 124
34 Infliximab therapy for intestinal, neurological, and vascular involvement in Behcet disease Toshifumi Hibi∥, Shunsei Hirohata, Hirotoshi Kikuchi et al. · Medicine Open access Jun 2016 121
35 Canagliflozin, a sodium glucose cotransporter 2 inhibitor, attenuates obesity-induced inflammation in the nodose ganglion, hypothalamus, and skeletal muscle of mice Farhana Naznin, Hideyuki Sakoda, Tadashi Okada et al. · European Journal of Pharmacology 19 Nov 2016 120
36 Expansion of T follicular helper-T helper 1 like cells through epigenetic regulation by signal transducer and activator of transcription factors Xiaoxue Ma, Shingo Nakayamada, Satoshi Kubo et al. · Annals of the Rheumatic Diseases 31 May 2018 118
37 First trough level of infliximab at week 2 predicts future outcomes of induction therapy in ulcerative colitis—results from a multicenter prospective randomized controlled trial and its post hoc analysis Taku Kobayashi, Yasuo Suzuki, Satoshi Motoya et al. · Journal of Gastroenterology Open access 10 Jul 2015 116
38 Perturbation of bile acid homeostasis is an early pathogenesis event of drug induced liver injury in rats Makoto Yamazaki, Manami Miyake, Hiroko Sato et al. · Toxicology and Applied Pharmacology 27 Jan 2013 113
39 MicroRNA expression profiles of neuron-derived extracellular vesicles in plasma from patients with amyotrophic lateral sclerosis Masataka Katsu, Yuka Hama, Jun Utsumi et al. · Neuroscience Letters 4 Jun 2019 107
40 Differential colon DNA damage induced by azo food additives between rats and mice Chihiro Shimada, Kiyoshi Kanô, Yu F. Sasaki et al. · The Journal of Toxicological Sciences Open access 2010 107
41 Developmental Inhibition of Gsk3 Rescues Behavioral and Neurophysiological Deficits in a Mouse Model of Schizophrenia Predisposition Makoto Tamura, Jun Mukai, Joshua A. Gordon et al. · Neuron Open access 20 Feb 2016 105
42 The XBP1 Arm of the Unfolded Protein Response Induces Fibrogenic Activity in Hepatic Stellate Cells Through Autophagy Rosa S. Kim, Daisuke Hasegawa, Nicolas Goossens et al. · Scientific Reports Open access 20 Dec 2016 103
43 Segmental HOG: new descriptor for glomerulus detection in kidney microscopy image Tsuyoshi Kato, Raissa Relator, Hayliang Ngouv et al. · BMC Bioinformatics Open access 30 Sep 2015 102
44 Positive emotions and brain reward circuits in chronic pain Edita Navratilova, Kozo Morimura, Jennifer Yanhua Xie et al. · The Journal of Comparative Neurology Open access 20 Jan 2016 100
45 Improved production of recombinant human antithrombin III in Chinese hamster ovary cells by ATF4 overexpression Tomoshi Ohya, Tetsuji Hayashi, Eriko Kiyama et al. · Biotechnology and Bioengineering 13 Dec 2007 98
46 The selective GSK3 inhibitor, SAR502250, displays neuroprotective activity and attenuates behavioral impairments in models of neuropsychiatric symptoms of Alzheimer’s disease in rodents Guy Griebel, Jeanne Stemmelin, Mati Lopez‐Grancha et al. · Scientific Reports Open access 2 Dec 2019 97
47 Antidepressant-like effects of the glucocorticoid receptor antagonist RU-43044 are associated with changes in prefrontal dopamine in mouse models of depression Yukio Ago, Shinsuke Arikawa, Miyuki Yata et al. · Neuropharmacology 31 Aug 2008 97
48 Apararenone in patients with diabetic nephropathy: results of a randomized, double-blind, placebo-controlled phase 2 dose–response study and open-label extension study Takashi Wada, Masaya Inagaki, Toru Yoshinari et al. · Clinical and Experimental Nephrology Open access 24 Sep 2020 96
49 Glycolysis, but not Mitochondria, responsible for intracellular ATP distribution in cortical area of podocytes Shota Ozawa, Shuko Ueda, Hiromi Imamura et al. · Scientific Reports Open access 18 Dec 2015 95
50 Interaction of the Sodium/Glucose Cotransporter (SGLT) 2 Inhibitor Canagliflozin with SGLT1 and SGLT2: Inhibition Kinetics, Sidedness of Action, and Transporter-Associated Incorporation Accounting for its Pharmacodynamic and Pharmacokinetic Features Ryuichi Ohgaki, Ling Wei, Kazunori Yamada et al. · Journal of Pharmacology and Experimental Therapeutics 28 Apr 2016 94

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.